Lei Xinhuan, Xiang Jie, Yang Hailan, Bao Hongya, Zhu Zhong, Luo Hua
Department of Orthopedic, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
Department of Ultrasound, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
EFORT Open Rev. 2023 Mar 14;8(3):127-134. doi: 10.1530/EOR-22-0130.
Surgical site infection (SSI) is a rare and serious complication of total knee arthroplasty (TKA), which causes a poor prognosis for patients. The purpose of this study was to explore the effect of intraosseous (IO) antibiotics in preventing infection and complications after TKA compared with intravenous (IV) antibiotics and to provide a certain theoretical basis for clinical treatment.
The review process was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched the PubMed, Embase, Ovid, Web of Science, and the Cochrane Central Register of Controlled Trials databases about trials on IO antibiotics (into the proximal tibia before skin incision) to prevent infections in TKA from the respective inception dates to September 30, 2022. The infection occurred within 3 months after surgery. Both researchers individually screened the studies in accordance with the inclusion and exclusion criteria, performed the literature quality evaluation and data extraction, and used Stata 17 software for data analysis.
Five studies that enrolled 3801 patients were included in this meta-analysis. The results showed that IO antibiotics were effective in reducing the incidence of SSI (OR: 0.25, P = 0.001) and periprosthetic joint infections (OR: 0.16, P = 0.004) relative to IV. Moreover, the percentage of infection due to Gram-positive bacteria (OR: 0.18, P = 0.025) was reduced in the IO group compared with that in IV group, but Gram-negative bacteria levels were not significantly reduced (P = 0.14). There was no difference between the two groups for other systemic adverse effects of the drug.
IO antibiotics in TKA are safe and effective alternatives to IV antibiotics. Large randomized clinical studies comparing infection rates and related complications with IO and IV antibiotics are required.
手术部位感染(SSI)是全膝关节置换术(TKA)罕见但严重的并发症,会导致患者预后不良。本研究旨在探讨与静脉注射(IV)抗生素相比,骨内(IO)抗生素在预防TKA术后感染及并发症方面的效果,并为临床治疗提供一定的理论依据。
按照系统评价和Meta分析的首选报告项目指南进行文献回顾。我们检索了PubMed、Embase、Ovid、科学网和Cochrane对照试验中央注册库数据库,以查找关于IO抗生素(在皮肤切口前注入胫骨近端)预防TKA感染的试验,检索时间从各数据库建库至2022年9月30日。感染发生在术后3个月内。两位研究者分别根据纳入和排除标准筛选研究,进行文献质量评估和数据提取,并使用Stata 17软件进行数据分析。
本Meta分析纳入了5项研究,共3801例患者。结果显示,与IV抗生素相比,IO抗生素在降低SSI发生率(OR:0.25,P = 0.001)和假体周围关节感染发生率(OR:0.16,P = 0.004)方面有效。此外,与IV组相比,IO组革兰氏阳性菌引起的感染百分比降低(OR:0.18,P = 0.025),但革兰氏阴性菌水平未显著降低(P = 0.14)。两组在药物的其他全身不良反应方面无差异。
TKA中使用IO抗生素是IV抗生素安全有效的替代方案。需要开展大型随机临床研究,比较IO和IV抗生素的感染率及相关并发症。